Approval · Notice of Compliance 5188 · 1995
ANAPROX: Notice of Compliance 5188
Issued April 24, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5188
- Date
- April 24, 1995
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Analgesic, anti-inflammatory agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANAPROX | 02162725 | Marketed |
| ANAPROX D.S. | 02162717 | Marketed |
Medicinal ingredients
- NAPROXEN SODIUM 275 MG per TAB
- NAPROXEN SODIUM 550 MG per TAB